Stonegate Capital Partners Updates Coverage on Fold Holdings Inc. (FLD) 1Q26
Dallas, Texas--(Newsfile Corp. - May 15, 2026) - Fold Holdings Inc. (NASDAQ: FLD): Stonegate Capital Partners Updates Coverage on Folding Holdings Inc. (NASDAQ: FLD). Fold's 1Q26 reflected bitcoin-market-driven pressure on activity, but the quarter did not change the core thesis; it shifted the FY26 focus toward conversion and scaling across products now in market. Revenue declined 21.1% y/y to $5.6M as transaction volume fell 32% y/y to $172M, while verified accounts approached 85K with...
2026-05-15 9:54 AM EDT
Stonegate Capital Partners Updates Coverage On Aemetis, Inc. (AMTX) 1Q26
Dallas, Texas--(Newsfile Corp. - May 14, 2026) - Aemetis, Inc. (NASDAQ: AMTX): Stonegate Capital Partners updates coverage on Aemetis, Inc. (NASDAQ: AMTX). Aemetis' 1Q26 further supports the transition from project buildout toward recurring low-carbon fuel monetization, with quarterly 45Z recognition and improving RNG economics beginning to appear in reported results. Revenue increased 27% y/y to $54.6M, gross profit improved to $2.8M from a $5.1M loss, and adj. EBITDA improved to negative...
2026-05-14 4:13 PM EDT
Tevard Biosciences Presents Preclinical Data Showing Complete Dystrophin Restoration and Robust Titin Rescue with Suppressor tRNA Therapy at ASGCT 2026
Boston, Massachusetts--(Newsfile Corp. - May 14, 2026) - Tevard Biosciences, Inc., a biotechnology company pioneering tRNA-based therapies to cure a broad range of genetic diseases, will share new preclinical data at the 2026 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting, held from May 11-15 in Boston. Tevard will present data demonstrating that its next-generation suppressor tRNAs (sup-tRNAs) restore full-length dystrophin protein and achieve wild-type levels of functional...
2026-05-14 7:37 AM EDT
Stonegate Capital Partners Updates Coverage on Valens Semiconductor Ltd. (VLN) 1Q26
Dallas, Texas--(Newsfile Corp. - May 13, 2026) - Valens Semiconductor Ltd. (NYSE: VLN): Stonegate Capital Partners Updates Coverage on Valens Semiconductor Ltd. (NYSE: VLN). Valens Semiconductor reported 1Q26 revenue of $16.9M, compared with $19.4M in 4Q25 and $16.8M in 1Q25. GAAP gross margin was 62.2%, above guidance of 57.0%-59.0%. Adjusted EBITDA loss was $(5.5)M, better than the guided range of $(7.9)M to $(7.5)M. While revenue stepped down sequentially following a stronger 4Q25, results...
2026-05-13 4:21 PM EDT
Stonegate Capital Partners Updates Coverage On Surf Air Mobility Inc. (SRFM) 1Q26
Dallas, Texas--(Newsfile Corp. - May 13, 2026) - Surf Air Mobility Inc. (NYSE: SRFM): Stonegate Capital Partners Updates Coverage on Surf Air Mobility Inc. (NYSE: SRFM). SRFM's 1Q26 results showed continued execution under the transformation plan, with revenue of $25.6M at the high end of guidance and up 9% y/y, while adjusted EBITDA loss of $12.3M outperformed guidance for a loss of $15.5M to $13.5M. Results were supported by improved On Demand private charter margins, cost controls across...
2026-05-13 9:34 AM EDT
Stonegate Capital Partners Updates Coverage on MarketWise (MKTW) 1Q26
Dallas, Texas--(Newsfile Corp. - May 12, 2026) - MarketWise (NASDAQ: MKTW): Stonegate Capital Partners Updates Coverage on MarketWise (NASDAQ: MKTW). MKTW's 1Q26 improved the forward setup by showing that the FY25 recovery is broadening into paid subscriber growth, higher ARPU, and reaffirmed FY26 cash flow targets. The reported GAAP revenue decline and negative CFFO understated underlying operating trends; revenue recognition continues to reflect older billings cohorts given the multi-year...
2026-05-12 5:18 PM EDT
Stonegate Capital Partners Updates Coverage on OS Therapies Inc. (OSTX)
Dallas, Texas--(Newsfile Corp. - May 12, 2026) - OS Therapies Inc. (NYSE American: OSTX): Stonegate Capital Partners updates their coverage on OS Therapies Inc. (NYSE American: OSTX). OS Therapies advanced materially through late-stage regulatory and commercialization preparation as OST-HER2 moved from Phase 2bsupported planning toward a more defined global approval pathway in recurrent, fully resected, pulmonary metastatic osteosarcoma. The key change is greater regulatory clarity: EMA...
2026-05-12 2:35 PM EDT
Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (VMD) 1Q26
Dallas, Texas--(Newsfile Corp. - May 12, 2026) - Viemed Healthcare, Inc. (NASDAQ: VMD). Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (NASDAQ: VMD). Viemed's 1Q26 results showed improving growth quality, not just reported scale. Sleep, resupply, and maternal health are becoming larger contributors, reducing reliance on legacy ventilation and improving capital efficiency. At the same time, ventilation appears to be moving through the NCD transition, with better...
2026-05-12 10:27 AM EDT
iOrganBio Appoints AI and Life Sciences Investor Jessica Owens to Its Board of Directors
Chapel Hill, North Carolina--(Newsfile Corp. - May 11, 2026) - iOrganBio, an innovator in intelligent cell manufacturing that is redefining how human cells are engineered and reliably produced at scale for research and therapeutic applications, including FDA-aligned New Approach Methodologies (NAMs), today announced the appointment of Jessica Owens to its Board of Directors. Jessica is a seasoned venture investor and serial founder with extensive experience building and scaling companies at...
2026-05-11 8:46 AM EDT
eyeo Raises 40 Million to Fix the Flaw That Has Kept Every Camera 70% Blind
Eindhoven, Netherlands--(Newsfile Corp. - May 11, 2026) - eyeo today announced it has raised 40 million in Series A funding, bringing eyeo's total funding to 55 million. The round is led by Innovation Industries, with participation from existing investors imec.xpand, Invest-NL Deep Tech Fund, QBIC fund, High-Tech Gründerfonds (HTGF) and Brabant Development Agency (BOM). To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Series A funds...
2026-05-11 5:10 AM EDT
Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 1Q26
Dallas, Texas--(Newsfile Corp. - May 8, 2026) - NU Skin Enterprises Inc. (NYSE: NUS): Stonegate Capital Partners updates their coverage on NU Skin Enterprises Inc. (NYSE: NUS). NUS reported revenue, adj NI, and adj EPS of $320.6M, $6.8M, and $0.14, respectively. This compares to our estimates of $329.7M, $7.7M, and $0.15, respectively. Revenue came in near the low end of guidance, while adjusted EPS remained within range as management continued investing behind Prysm iO and emerging markets...
2026-05-08 1:34 PM EDT
Stonegate Capital Partners Updates Coverage on OppFi, Inc. (OPFI) 1Q26
Dallas, Texas--(Newsfile Corp. - May 8, 2026) - OppFi, Inc. (NYSE: OPFI): Stonegate Capital Partners Updates Coverage on OppFi (NYSE: OPFI). OppFi's 1Q26 results were steady, but the bigger development was its shift toward a bank-enabled, deposit-funded model through the pending BNCC acquisition. Revenue and receivables grew despite lower originations, as tighter credit, inflation, weaker sentiment, and higher average tax refunds temporarily reduced loan demand. Higher charge-offs pressured...
2026-05-08 10:25 AM EDT
Stonegate Capital Partners Updates Coverage on BlackSky Technology, Inc. (BKSY) 1Q26
Dallas, Texas--(Newsfile Corp. - May 7, 2026) - BlackSky Technology, Inc. (NYSE: BKSY): Stonegate Capital Partners Updates Coverage on BlackSky Technology, Inc. (NYSE: BKSY). BKSY's 1Q26 marked a clearer Gen-3 commercialization inflection, with accelerating sovereign contract adoption, improving in-year revenue visibility, and management raising FY26 revenue and adj. EBITDA guidance. While reported revenue remained affected by Mission Solutions timing, the more important development was the...
2026-05-07 5:04 PM EDT
Stonegate Capital Partners Updates Coverage on Gladstone Commercial Corp. (GOOD) 1Q26
Dallas, Texas--(Newsfile Corp. - May 7, 2026) - Gladstone Commercial Corp. (NASDAQ: GOOD): Stonegate Capital Partners Updates Coverage on Gladstone Commercial Corp. (NASDAQ: GOOD). GOOD reported revenue, FFO per share, and AFFO per share of $41.9M, $0.35, and $0.30, respectively. This compares to our/consensus estimates of $43.5M/$42.9M, $0.36/$0.35, and $0.25/$0.26. The q/q decline appears largely tied to 4Q25 items, including a lease termination fee and easement settlement, rather than a...
2026-05-07 4:30 PM EDT
MedCognetics and AWS Bring AI-Powered Breast Cancer Screening to Underserved Communities in India
Dallas, Texas--(Newsfile Corp. - May 7, 2026) - MedCognetics, Inc., a company focusing on medical imaging AI, today and a member of the Amazon Web Services (AWS) Partner Network (APN), announced a collaboration with Health Within Reach Foundation (HWRF), a nonprofit striving to bring quality healthcare within reach for the underprivileged, to deploy AI-enabled mobile mammography units in India, bringing critical breast cancer screening services directly to underserved populations. To view the...
2026-05-07 12:24 PM EDT
A Shift From "Summer Ready" to System-Level Health via the Superhuman Protocol Challenge
New York, New York--(Newsfile Corp. - May 7, 2026) - The April 2026 Wellness Index Report has identified three top-rated U.S. wellness providers leading the nationwide Superhuman Protocol Challenge, signaling a shift away from seasonal weight-loss trends toward cellular-level health optimization. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: The April 2026 Wellness Index Report signals a shift from seasonal weight-loss trends to...
2026-05-07 7:09 AM EDT
MilliporeSigma Builds On its Legacy As a Biotechnology Leader in Temecula
Temecula, California--(Newsfile Corp. - May 5, 2026) - Since first establishing operations in Temecula in 1989, MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has grown its Temecula site into a center for advanced biomedical and biotechnical manufacturing. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: MilliporeSigma has been in Temecula since 1989 and has steadily expanded the site into a...
2026-05-05 2:22 PM EDT
Stonegate Capital Partners Updates Coverage on Civeo Corporation (CVEO) Q126
Dallas, Texas--(Newsfile Corp. - May 4, 2026) - Civeo Corporation (NYSE: CVEO) Stonegate Capital Partners Updates Coverage on Civeo Corporation (NYSE: CVEO). CVEO reported revenue and adj EBITDA of $172.7M and $22.5M, respectively. This compares to our/consensus estimates of $154.6M/$154.7M and $16.3M/$16.8M, respectively. Net loss improved to $3.8M from $9.8M in 1Q25, while operating cash flow was $(9.7)M, reflecting typical seasonal working capital use. Capex remained modest at $4.1M and...
2026-05-04 9:45 AM EDT
Stonegate Capital Partners Updates Coverage on Provident Financial Services Inc (PFS) 1Q26
Dallas, Texas--(Newsfile Corp. - May 4, 2026) - Provident Financial Services, Inc. (NYSE: PFS): Stonegate Capital Partners Updates Coverage on Provident Financial Services, Inc. (NYSE: PFS). Provident Financial Services delivered a steady 1Q26, with the post-Lakeland profitability profile holding despite lower q/q EPS and a more visible credit watch item. Net income was $79.4M, or $0.61 diluted EPS, versus $83.4M, or $0.64, in 4Q25, while ROAA was 1.29%, Pre-provision net-revenue ROAA was...
2026-05-04 9:42 AM EDT
Stonegate Updates Coverage on NCS Multistage Holdings, Inc. (NCSM) Q126
Dallas, Texas--(Newsfile Corp. - May 1, 2026) - NCS Multistage Holdings, Inc. (NASDAQ: NCSM): Stonegate Capital Partners Updates Coverage on NCS Multistage Holdings, Inc. (NASDAQ: NCSM). NCSM's 1Q26 came in below expectations as Canada and select international projects weighed on results, while continued U.S. momentum helped offset the shortfall. In our view, the quarter does not change the core thesis around U.S. product momentum, ResMetrics integration, and the Company's capital-light...
2026-05-01 9:47 AM EDT